MODASAFE 300

What is MODASAFE 300?

MODASAFE 300 is a modern pharmaceutical agent from the group of psychostimulants and nootropic drugs, which is used to combat pathological daytime sleepiness. The active substance of the drug is modafinil, a substance with a unique mechanism of action on the central nervous system that distinguishes it from classical amphetamine-class psychostimulants. The manufacturer of MODASAFE 300 is the Indian pharmaceutical company Fortune Healthcare, which has many years of experience in producing high-quality generics that comply with international GMP standards. The drug is produced in the form of oral tablets with a dosage of 300 mg of the active substance in one tablet, which is a convenient format for selecting an individual therapeutic regimen.

The pharmacological group to which MODASAFE 300 belongs is defined as analeptics and agents that stimulate the non-specific activating system of the brain. Unlike traditional stimulants, modafinil does not cause pronounced agitation and nervousness, but acts more gently, maintaining a state of wakefulness without the euphoria characteristic of amphetamines. This makes MODASAFE 300 the drug of choice for patients who require correction of the sleep-wake cycle without the risk of developing classical stimulant addiction. Clinical studies of modafinil have been ongoing for more than two decades, which has made it possible to accumulate a significant body of evidence regarding its efficacy and safety.

MODASAFE 300 from Fortune Healthcare belongs to the category of generics — reproduced drugs that contain an active substance identical to the original drug, but are offered at a more affordable price. This makes modafinil therapy more accessible to a wide range of patients who need correction of sleep disorders. It is worth noting that despite its generic status, the drug undergoes the necessary quality control and meets pharmacopoeial requirements. The use of MODASAFE 300 should take place exclusively as prescribed by a physician, as self-adjustment of the dosage can lead to undesirable health consequences.

What is MODASAFE 300 prescribed for?

The main indication for the use of MODASAFE 300 is narcolepsy — a neurological disorder characterized by sudden attacks of overwhelming sleepiness and disruption of sleep cyclicity. Patients with this diagnosis experience episodes of falling asleep at inappropriate times, which significantly reduces the quality of life and poses a danger when driving or performing responsible work. MODASAFE 300 helps to stabilize wakefulness throughout the day, reducing the frequency and intensity of sleepiness attacks. The therapeutic effect is usually noticeable within the first weeks of use, although a full evaluation of efficacy requires longer observation.

Another important indication is obstructive sleep apnea syndrome — a condition in which periodic breathing pauses at night lead to sleep fragmentation and chronic daytime fatigue. MODASAFE 300 in such cases is used as an adjunctive agent alongside the main apnea therapy, such as CPAP therapy, rather than as its replacement. The drug can also be prescribed for shift work sleep disorder, when night shift workers face a chronic deficit of alertness during working hours. This condition negatively affects concentration and productivity, and modafinil helps restore an adequate level of cognitive functioning.

In some clinical cases, MODASAFE 300 is used off-label to correct excessive fatigue in depressive disorders or as an adjunctive agent in chronic fatigue syndrome. However, such use must take place strictly under the supervision of a physician who evaluates the benefit-risk ratio for a specific patient. It is important to understand that MODASAFE 300 is not a means to increase work capacity in healthy people without medical indications, and its use for this purpose is not recommended due to potential side effects and the lack of a sufficient evidence base regarding the safety of such application.

Composition and active components of MODASAFE 300

The main active component of MODASAFE 300 is modafinil at a dosage of 300 mg per tablet. By its chemical structure, this substance belongs to benzhydrylsulfinylacetamide derivatives and has a specific mechanism of action that differs from amphetamines and other classical psychostimulants. Modafinil affects the hypothalamic structures of the brain, in particular the orexin (hypocretin) system, which is responsible for regulating the sleep-wake cycle. The substance also modulates the levels of dopamine, norepinephrine, and histamine in certain areas of the central nervous system, which helps maintain wakefulness without pronounced stimulation of motor activity.

Excipients of the MODASAFE 300 tablet include standard pharmaceutical fillers such as microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, povidone, and magnesium stearate. These substances provide the necessary tablet consistency, disintegration rate in the gastrointestinal tract, and stability of the drug during its shelf life. Patients with lactose intolerance should inform their doctor before starting therapy, as excipients can cause an individual reaction even in the absence of problems with the main active component.

The mechanism of action of modafinil is still being studied by scientists, but it is known that the substance does not directly affect receptors associated with classical addiction, as occurs with amphetamines. This explains the lower potential for abuse of MODASAFE 300 compared to traditional psychostimulants. However, this does not mean a complete absence of the risk of developing psychological dependence with prolonged uncontrolled use, so adherence to the treatment regimen prescribed by a doctor is critically important.

Dosage of MODASAFE 300

The standard recommended dose of MODASAFE 300 for adult patients with narcolepsy or obstructive sleep apnea syndrome is 200-400 mg per day, which often corresponds to one tablet of the drug taken once in the morning. For patients with shift work sleep disorder, the drug is usually taken approximately one hour before the start of the work shift. The doctor determines the specific dosage individually, taking into account the patient's weight, concomitant diseases, response to previous therapy, and severity of symptoms. Self-increasing the dose without consulting a specialist is strictly not recommended, as this increases the risk of developing side effects without additional therapeutic gain.

The duration of the course of treatment with MODASAFE 300 is determined individually depending on the main diagnosis and the dynamics of the clinical picture. In chronic conditions such as narcolepsy, therapy can last for months or even years under regular medical supervision. Dosage adjustment may be required in elderly patients, as well as in cases of impaired liver function, since modafinil metabolism occurs mainly in the liver, and a decrease in its functional activity can lead to accumulation of the substance in the body. In such cases, the doctor may recommend a reduced initial dose with subsequent gradual titration if necessary.

How to take MODASAFE 300 correctly?

The MODASAFE 300 tablet should be taken orally with a sufficient amount of water, regardless of food intake, although some patients report better tolerability when taken after breakfast. The optimal time of administration is the morning hours, as this allows maintaining alertness throughout the day and minimizes the risk of night sleep disturbance. In the case of prescribing the drug for the correction of sleep disorder in shift work, administration is carried out immediately before the start of the work shift, usually 60 minutes before it. It is important to adhere to the same time of administration daily to maintain a stable concentration of the active substance in the blood.

If a regular dose of MODASAFE 300 was missed, it is not recommended to take a double dose to compensate for the missed one. Instead, you should continue taking it according to the usual schedule from the next scheduled time, especially if a lot of time has passed since the missed dose or evening is approaching, as late administration can negatively affect night sleep. Patients starting MODASAFE 300 therapy for the first time should closely monitor their well-being during the first days of intake and inform their doctor of any unusual body reactions, as individual sensitivity to modafinil can vary significantly.

Side effects of MODASAFE 300

Among the most common side effects of MODASAFE 300, patients note headache, dry mouth, nausea, anxiety, and night sleep disturbances in the form of insomnia. These manifestations are usually of moderate intensity and may decrease as the body adapts to the drug during the first weeks of therapy. An increase in blood pressure and an increased heart rate are also possible, so patients with cardiovascular diseases require regular monitoring of relevant parameters during treatment.

Uncommon adverse reactions include dizziness, decreased appetite, diarrhea or, conversely, constipation, as well as increased irritability and anxiety. In rare cases, skin reactions in the form of a rash may occur, requiring immediate discontinuation of the drug and consulting a doctor, as there is a theoretical risk of developing serious dermatological reactions, including Stevens-Johnson syndrome. Rare but serious side effects are psychiatric disorders such as hallucinations, severe anxiety, or depressive episodes.

You should consult a doctor immediately if any signs of an allergic reaction appear, such as swelling of the face or throat, difficulty breathing, as well as in case of chest pain, irregular heartbeat, or severe psychiatric changes. It is worth remembering that the body's reaction to MODASAFE 300 is individual, and what is well tolerated by one patient may cause pronounced side effects in another, so careful monitoring of your well-being throughout the entire course of treatment is mandatory.

Contraindications of MODASAFE 300

Absolute contraindications to the use of MODASAFE 300 are confirmed hypersensitivity to modafinil or any excipient of the drug, severe uncontrolled cardiovascular diseases, including unstable angina and a history of arrhythmias, as well as severe arterial hypertension. The drug is not prescribed to patients with acute psychotic disorders or a history of severe anxiety, as modafinil can exacerbate such conditions. Severe hepatic impairment is also a contraindication requiring alternative approaches to the treatment of sleep disorders.

Relative contraindications requiring special caution and increased medical supervision are moderate arterial hypertension, mitral valve prolapse, moderate liver impairment, and renal failure. In elderly patients, MODASAFE 300 is prescribed with caution due to possible slowing down of metabolism and increased sensitivity to side effects from the cardiovascular system. The use of the drug by children and adolescents under 18 years of age is not recommended due to insufficient clinical data on safety in this age category.

Pregnancy and breastfeeding are a separate category that requires special attention: MODASAFE 300 is not recommended for use in pregnant women due to insufficient study of the effect of modafinil on fetal development, and available data indicate a potential risk. Women of reproductive age taking the drug should discuss reliable methods of contraception with their doctor, as modafinil can reduce the efficacy of hormonal contraceptives. During lactation, the use of the drug should also be agreed with a doctor, taking into account the possibility of the active substance penetrating into breast milk.

Interaction of MODASAFE 300 with other drugs and alcohol

MODASAFE 300 is capable of entering into clinically significant interactions with a number of drugs through its effect on the liver enzyme system, in particular cytochrome P450. The drug can reduce the effectiveness of hormonal contraceptives, anticoagulants, certain anticonvulsants, and immunosuppressants, which requires dosage adjustment of concomitant therapy or the use of alternative methods of contraception. Concomitant use of MODASAFE 300 with other psychostimulants, antidepressants of the monoamine oxidase inhibitor group, or drugs affecting the cardiovascular system requires mandatory consultation with a doctor due to the increased risk of developing adverse effects. It is important to inform your doctor about all drugs, including herbal products and dietary supplements, taken simultaneously with MODASAFE 300.

Alcohol consumption during MODASAFE 300 therapy is strictly not recommended, as ethanol can increase the strain on the cardiovascular system and neutralize the therapeutic effect of the drug aimed at maintaining wakefulness. Regarding driving vehicles, although MODASAFE 300 is intended precisely to maintain concentration in sleep disorders, at the beginning of therapy you should refrain from driving until evaluating the individual response of the body to the drug, as individual patients may experience dizziness or other side effects affecting reaction speed.

Where to buy MODASAFE 300 in Ukraine

You can purchase MODASAFE 300 in pharmacy chains if you have a prescription from a doctor, as the drug belongs to controlled substances due to its potential impact on the central nervous system. Some specialized online pharmacies also offer the option to order the drug with subsequent delivery, but it is important to ensure the reliability of the supplier and the availability of necessary documents confirming the quality and origin of the medicine. Before buying, it is worth consulting a doctor who will not only confirm the appropriateness of using MODASAFE 300, but also help select the optimal dosage in accordance with individual health characteristics.

It is recommended to store MODASAFE 300 at room temperature, in a dry place protected from direct sunlight and out of reach of children. Compliance with storage conditions is important to maintain the stability of the active substance and therapeutic efficacy of the drug throughout the entire shelf life indicated on the package. Before starting to use MODASAFE 300, be sure to consult a doctor to exclude contraindications and receive individual recommendations, as the body's response to modafinil is purely individual and requires professional medical supervision throughout the course of therapy.